Squamous cell carcinoma of rectum
MONDO:0018515A very rare rectal carcinoma characterized by the presence of a malignant squamous cell infiltrate.
Also known as: rectal squamous carcinoma, rectal squamous cell cancer, rectal squamous cell carcinoma, rectum squamous cell carcinoma, squamous carcinoma of rectum, squamous carcinoma of the rectum, squamous cell carcinoma of rectum, squamous cell carcinoma of the rectum
2933 clinical trials for this condition and its sub-types, 8 tagged with Squamous cell carcinoma of rectum itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Squamous cell carcinoma of rectum
-
Anal squamous cell carcinoma 40 trials · 49 incl. sub-types
4 sub-types
- Anal canal squamous cell carcinoma 12 trials
- Anal margin squamous cell carcinoma 4 trials
- Anus basaloid carcinoma 3 trials
- Anal verrucous carcinoma 0 trials
-
Rectal adenosquamous carcinoma 0 trials
-
Rectal cloacogenic carcinoma 0 trials
-
New triple therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs—bintrafusp alfa, PDS01ADC, and entinostat—in adults with advanced HPV-related cancers (like cervical, anal, or throat cancer) or certain colon cancers that haven't responded to standard treatment. The goal is to find a safe dose and s…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New trial tailors anal cancer treatment for people with HIV
Disease control OngoingThis phase 2 trial is testing whether adjusting treatment based on risk level can improve outcomes for people with HIV who have anal cancer. Low-risk patients receive standard chemotherapy and radiation, while high-risk patients also get the immunotherapy drug nivolumab after sta…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Custom immune cells take on multiple cancers in early trial
Disease control OngoingThis early-stage study tests a new treatment called T-Plex for people with advanced solid tumors (like head and neck, cervical, or melanoma) that haven't responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and…
Phase 1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC